Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients

NCT06567418 · clinicaltrials.gov ↗

RECRUITING

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: alirocumab 75mg/2week
DRUG: statin ± ezetimibe

Sponsor

Yun Dai Chen

Collaborators

[object Object]